Fusion event
HBV-chr21 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Region type
X protein|Polymerase|
Integrated sequence
TTGGGACTCTCTCGTCCCCTTCTCCGTCTGCCGTTCCGACCGACCACGGGGCGCACCTCTCTTTACGCGGACTCCCCGTCTGTGCCTTCTCATCTGCCGG| |ACCGTGTGCACTTCGCTTCACCTCTGCACGTCGCATGGAGACCACCGTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTC
End
48119857/46699945 (Hg38)
Nearest miRNA
hsa-let-7c/Upstream/1221619;
Upstream sequence
tgagggtgagggtgagggtgagggttaggggttagggttagggttagggttagggttagggttagggttagggttagggttagggttagggttagggtta
Downstream sequence
gggttagggttgggttagggttagggttagggttagggNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.